Indonesia · Delayed Price · Currency is IDR PT Dharma Polimetal Tbk Statistics
Total Valuation
IDX:DRMA has a market cap or net worth of IDR 4.71 trillion. The enterprise value is 4.68 trillion.
| Market Cap | 4.71T |
| Enterprise Value | 4.68T |
Important Dates
The next estimated earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Apr 28, 2026 |
Share Statistics
IDX:DRMA has 4.71 billion shares outstanding.
| Current Share Class | 4.71B |
| Shares Outstanding | 4.71B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.75% |
| Owned by Institutions (%) | 3.98% |
| Float | 1.01B |
Valuation Ratios
The trailing PE ratio is 6.77 and the forward PE ratio is 6.95.
| PE Ratio | 6.77 |
| Forward PE | 6.95 |
| PS Ratio | 0.74 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | 8.38 |
| P/OCF Ratio | 5.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.16, with an EV/FCF ratio of 8.34.
| EV / Earnings | 6.73 |
| EV / Sales | 0.74 |
| EV / EBITDA | 4.16 |
| EV / EBIT | 5.55 |
| EV / FCF | 8.34 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.84 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.65 |
| Interest Coverage | 30.55 |
Financial Efficiency
Return on equity (ROE) is 26.30% and return on invested capital (ROIC) is 23.69%.
| Return on Equity (ROE) | 26.30% |
| Return on Assets (ROA) | 12.08% |
| Return on Invested Capital (ROIC) | 23.69% |
| Return on Capital Employed (ROCE) | 24.73% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 2.72B |
| Profits Per Employee | 299.48M |
| Employee Count | 2,322 |
| Asset Turnover | 1.53 |
| Inventory Turnover | 7.46 |
Taxes
In the past 12 months, IDX:DRMA has paid 178.44 billion in taxes.
| Income Tax | 178.44B |
| Effective Tax Rate | 20.14% |
Stock Price Statistics
The stock price has increased by +5.73% in the last 52 weeks. The beta is 0.19, so IDX:DRMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +5.73% |
| 50-Day Moving Average | 930.10 |
| 200-Day Moving Average | 1,000.13 |
| Relative Strength Index (RSI) | 77.65 |
| Average Volume (20 Days) | 587,770 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:DRMA had revenue of IDR 6.32 trillion and earned 695.40 billion in profits. Earnings per share was 147.77.
| Revenue | 6.32T |
| Gross Profit | 1.14T |
| Operating Income | 799.95B |
| Pretax Income | 885.83B |
| Net Income | 695.40B |
| EBITDA | 1.08T |
| EBIT | 799.95B |
| Earnings Per Share (EPS) | 147.77 |
Balance Sheet
The company has 539.47 billion in cash and 362.47 billion in debt, with a net cash position of 177.00 billion or 37.61 per share.
| Cash & Cash Equivalents | 539.47B |
| Total Debt | 362.47B |
| Net Cash | 177.00B |
| Net Cash Per Share | 37.61 |
| Equity (Book Value) | 2.88T |
| Book Value Per Share | 579.98 |
| Working Capital | 998.11B |
Cash Flow
In the last 12 months, operating cash flow was 877.58 billion and capital expenditures -315.99 billion, giving a free cash flow of 561.58 billion.
| Operating Cash Flow | 877.58B |
| Capital Expenditures | -315.99B |
| Depreciation & Amortization | 281.21B |
| Net Borrowing | -91.13B |
| Free Cash Flow | 561.58B |
| FCF Per Share | 119.34 |
Margins
Gross margin is 18.03%, with operating and profit margins of 12.65% and 11.00%.
| Gross Margin | 18.03% |
| Operating Margin | 12.65% |
| Pretax Margin | 14.01% |
| Profit Margin | 11.00% |
| EBITDA Margin | 17.10% |
| EBIT Margin | 12.65% |
| FCF Margin | 8.88% |
Dividends & Yields
This stock pays an annual dividend of 70.00, which amounts to a dividend yield of 7.04%.
| Dividend Per Share | 70.00 |
| Dividend Yield | 7.04% |
| Dividend Growth (YoY) | 62.79% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 47.37% |
| Buyback Yield | n/a |
| Shareholder Yield | 7.04% |
| Earnings Yield | 14.78% |
| FCF Yield | 11.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for IDX:DRMA is 1,412.00, which is 39.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,412.00 |
| Price Target Difference | 39.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 7.57% |
| EPS Growth Forecast (3Y) | 6.10% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:DRMA has an Altman Z-Score of 4.75 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.75 |
| Piotroski F-Score | 7 |